362 related articles for article (PubMed ID: 11380039)
1. Conventional treatment of Crohn's disease: objectives and outcomes.
Rutgeerts PJ
Inflamm Bowel Dis; 2001 May; 7 Suppl 1():S2-8. PubMed ID: 11380039
[TBL] [Abstract][Full Text] [Related]
2. Methotrexate for induction of remission in refractory Crohn's disease.
McDonald JW; Tsoulis DJ; Macdonald JK; Feagan BG
Cochrane Database Syst Rev; 2012 Dec; 12():CD003459. PubMed ID: 23235598
[TBL] [Abstract][Full Text] [Related]
3. Approach to corticosteroid-dependent and corticosteroid-refractory Crohn's disease.
Lichtenstein GR
Inflamm Bowel Dis; 2001 May; 7 Suppl 1():S23-9. PubMed ID: 11380040
[TBL] [Abstract][Full Text] [Related]
4. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
Nørgård BM
Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
[TBL] [Abstract][Full Text] [Related]
5. Maintenance of symptomatic remission in patients with Crohn's disease.
Stark ME; Tremaine WJ
Mayo Clin Proc; 1993 Dec; 68(12):1183-90. PubMed ID: 7902474
[TBL] [Abstract][Full Text] [Related]
6. Initial therapy for mild to moderate Crohn's disease: mesalamine or budesonide?
Feagan BG; Sandborn WJ
Rev Gastroenterol Disord; 2002; 2 Suppl 2():S9-15. PubMed ID: 12478239
[TBL] [Abstract][Full Text] [Related]
7. Aminosalicylates for induction of remission or response in Crohn's disease.
Lim WC; Hanauer S
Cochrane Database Syst Rev; 2010 Dec; (12):CD008870. PubMed ID: 21154400
[TBL] [Abstract][Full Text] [Related]
8. Corticosteroid-sparing treatments in patients with Crohn's disease.
Plevy SE
Am J Gastroenterol; 2002 Jul; 97(7):1607-17. PubMed ID: 12135008
[TBL] [Abstract][Full Text] [Related]
9. Current treatment for prevention of relapse and recurrence in Crohn's disease.
Prantera C; Scribano ML
Ital J Gastroenterol Hepatol; 1999; 31(6):515-8. PubMed ID: 10575572
[TBL] [Abstract][Full Text] [Related]
10. Review article: maintenance treatment of Crohn's disease.
Biancone L; Tosti C; Fina D; Fantini M; De Nigris F; Geremia A; Pallone F
Aliment Pharmacol Ther; 2003 Jun; 17 Suppl 2():31-7. PubMed ID: 12786610
[TBL] [Abstract][Full Text] [Related]
11. A comparison of budesonide and mesalamine for active Crohn's disease.
Lowry PW; Sandborn WJ
Gastroenterology; 1999 May; 116(5):1263. PubMed ID: 10220523
[No Abstract] [Full Text] [Related]
12. Review article: mild to moderate Crohn's disease--defining the basis for a new treatment algorithm.
Sandborn WJ; Feagan BG
Aliment Pharmacol Ther; 2003 Aug; 18(3):263-77. PubMed ID: 12895211
[TBL] [Abstract][Full Text] [Related]
13. Medical management of mild to moderate Crohn's disease: evidence-based treatment algorithms for induction and maintenance of remission.
Sandborn WJ; Feagan BG; Lichtenstein GR
Aliment Pharmacol Ther; 2007 Oct; 26(7):987-1003. PubMed ID: 17877506
[TBL] [Abstract][Full Text] [Related]
14. Review article: chronic active disease and maintaining remission in Crohn's disease.
Kamm MA
Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():102-5. PubMed ID: 15352904
[TBL] [Abstract][Full Text] [Related]
15. Conventional therapy for moderate to severe inflammatory bowel disease: A systematic literature review.
Damião AOMC; de Azevedo MFC; Carlos AS; Wada MY; Silva TVM; Feitosa FC
World J Gastroenterol; 2019 Mar; 25(9):1142-1157. PubMed ID: 30863001
[TBL] [Abstract][Full Text] [Related]
16. Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Luminal Crohn's Disease.
Panaccione R; Steinhart AH; Bressler B; Khanna R; Marshall JK; Targownik L; Afif W; Bitton A; Borgaonkar M; Chauhan U; Halloran B; Jones J; Kennedy E; Leontiadis GI; Loftus EV; Meddings J; Moayyedi P; Murthy S; Plamondon S; Rosenfeld G; Schwartz D; Seow CH; Williams C; Bernstein CN
Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1680-1713. PubMed ID: 30853616
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of Crohn's disease].
Beglinger Ch
Ther Umsch; 2003 Mar; 60(3):159-63. PubMed ID: 12693319
[TBL] [Abstract][Full Text] [Related]
18. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
Prefontaine E; Macdonald JK; Sutherland LR
Cochrane Database Syst Rev; 2009 Oct; (4):CD000545. PubMed ID: 19821270
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine.
Bouhnik Y; Lémann M; Mary JY; Scemama G; Taï R; Matuchansky C; Modigliani R; Rambaud JC
Lancet; 1996 Jan; 347(8996):215-9. PubMed ID: 8551879
[TBL] [Abstract][Full Text] [Related]
20. Medical management of Crohn's disease.
Cottone M; Renna S; Orlando A; Mocciaro F
Expert Opin Pharmacother; 2011 Nov; 12(16):2505-25. PubMed ID: 21988215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
